Researchers described results as 'an important first step' in potentially developing new treatment for people with advanced cancers.

WEDNESDAY, Sept. 4, 2024 -- Current vaccines against mpox were designed to fight an older, rarer cousin of the virus, smallpox.Now, new research from...

KalVista announces FDA acceptance of New Drug Application for sebetralstat for oral on-demand treatment of hereditary angioedema KalVista...

South East Development Peace Initiative (SPDI) has hailed the recent breakthrough by the Nigerian Army in the fight against terrorism in the North...

South East Development Peace Initiative (SPDI) has hailed the recent breakthrough by the Nigerian Army in the fight against terrorism in the North...

South East Development Peace Initiative (SPDI) has hailed the recent breakthrough by the Nigerian Army in the fight against terrorism in the North...

Scientists have made a major breakthrough in neuroscience, developing a novel RNA-based nasal spray, COG-201, that has shown remarkable promise in...

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--Sep. 3, 2024-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the U.S....

An experimental mRNA cancer vaccine shows promising results in a Phase 1 trial, potentially offering new hope for advanced-stage cancer patients.

Metronidazole is a standard treatment drug for Trichomoniasis; however, it has high breakthrough rate. Studies ongoing to change to alternate...